Over the last 2 years, different cases of immune thrombocytopenia (ITP) in patients affected by SARS-CoV2 have been reported. The management of SARS-CoV2 in subjects with simultaneous or previous ITP can be challenging because of the great involvement of the haemostatic system in this viral infection. In this report,wedescribe themanagement and outcome of patients with newly diagnosed (ND), chronic and previous ITP, infected by COVID-19, referred to the Haematology Institute of University HospitalPoliclinicoUmberto I inRome. Steroids+immunoglobulins forNDor relapsed ITP and continuation of home therapy for chronic ITP are advised, although further knowledge is required.
Immune thrombocytopenia management during COVID-19 pandemic: An Italian monocentric experience / Lapietra, Gianfranco; Ferretti, Antonietta; Baldacci, Erminia; Chistolini, Antonio; Santoro, Cristina. - In: EJHAEM. - ISSN 2688-6146. - (2021).
Immune thrombocytopenia management during COVID-19 pandemic: An Italian monocentric experience
Gianfranco LapietraPrimo
;Antonietta FerrettiSecondo
;Erminia Baldacci;Antonio ChistoliniPenultimo
;Cristina Santoro
2021
Abstract
Over the last 2 years, different cases of immune thrombocytopenia (ITP) in patients affected by SARS-CoV2 have been reported. The management of SARS-CoV2 in subjects with simultaneous or previous ITP can be challenging because of the great involvement of the haemostatic system in this viral infection. In this report,wedescribe themanagement and outcome of patients with newly diagnosed (ND), chronic and previous ITP, infected by COVID-19, referred to the Haematology Institute of University HospitalPoliclinicoUmberto I inRome. Steroids+immunoglobulins forNDor relapsed ITP and continuation of home therapy for chronic ITP are advised, although further knowledge is required.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
